206 US-listed healthcare companies worth over $1 billion pass the Shariah screen — 70% of the 295 screened. The largest are Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK) and UnitedHealth Group Incorporated (UNH). Each passes AAOIFI's two balance-sheet limits (interest-bearing debt, and cash plus short-term investments, each under 30% of market cap) and is not in an excluded line of business.
| # | Company | Industry | Market cap | Debt / mkt cap | Cash / mkt cap |
|---|---|---|---|---|---|
| 1 | LLY Eli Lilly and Company | Drug Manufacturers - General | $1.32T | 3.7% | 0.4% |
| 2 | JNJ Johnson & Johnson | Drug Manufacturers - General | $671.3B | 6.6% | 2.5% |
| 3 | ABBV AbbVie Inc. | Drug Manufacturers - General | $516.3B | 15.5% | 2.1% |
| 4 | MRK Merck & Co., Inc. | Drug Manufacturers - General | $353.8B | 15.1% | 2.7% |
| 5 |
The 40 largest of 206. Filter all of them in the halal stock screener.
206 US-listed healthcare companies worth over $1 billion pass the Shariah screen, out of 295 screened, as of November 17, 2026.
Eli Lilly and Company (LLY) passes the screen: debt is 3.7% and cash and short-term investments 0.4% of its market cap, both under AAOIFI's 30% limit, and its business (Drug Manufacturers - General) is not excluded.
Every US-listed company goes through the halal stock screener: interest-bearing debt and cash plus short-term investments, each under 30% of market cap (AAOIFI's limits, the strictest of the five published sets), and no bank, insurance, credit, asset management, alcohol, tobacco or gambling business. The interest-income test is not run on the list; each company's own page runs all five standards. Updated daily.
Tools: the halal stock screener, the ETF halal check, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and each company's line of business, not a religious ruling and not a recommendation to buy. It does not test income from excluded activities; check with a scholar you trust.
| UNH UnitedHealth Group Incorporated |
| Medical - Healthcare Plans | $347.5B | 20.1% | 8.2% |
| 6 | TMO Thermo Fisher Scientific Inc. | Medical - Diagnostics & Research | $254.4B | 16.2% | 2.4% |
| 7 | AMGN Amgen Inc. | Drug Manufacturers - General | $247.0B | 21.6% | 5.3% |
| 8 | GILD Gilead Sciences, Inc. | Drug Manufacturers - General | $210.1B | 12.6% | 3.1% |
| 9 | ABT Abbott Laboratories | Medical - Devices | $181.9B | 16.7% | 2.4% |
| 10 | DHR Danaher Corporation | Medical - Diagnostics & Research | $158.8B | 16.4% | 3.6% |
| 11 | ISRG Intuitive Surgical, Inc. | Medical - Instruments & Supplies | $149.7B | 0.0% | 2.7% |
| 12 | VRTX Vertex Pharmaceuticals Incorporated | Biotechnology | $135.0B | 3.3% | 4.7% |
| 13 | MCK McKesson Corporation | Medical - Distribution | $125.6B | 7.2% | 5.2% |
| 14 | SYK Stryker Corporation | Medical - Devices | $120.2B | 12.8% | 2.7% |
| 15 | REGN Regeneron Pharmaceuticals, Inc. | Biotechnology | $98.6B | 2.0% | 9.6% |
| 16 | MRNA Moderna, Inc. | Biotechnology | $83.7B | 4.1% | 6.2% |
| 17 | COR Cencora, Inc. | Medical - Distribution | $67.0B | 16.5% | 7.3% |
| 18 | CAH Cardinal Health, Inc. | Medical - Distribution | $64.8B | 13.4% | 8.1% |
| 19 | BSX Boston Scientific Corporation | Medical - Devices | $62.5B | 18.9% | 1.0% |
| 20 | EW Edwards Lifesciences Corporation | Medical - Devices | $61.0B | 1.0% | 7.6% |
| 21 | BDX Becton, Dickinson and Company | Medical - Instruments & Supplies | $58.8B | 27.7% | 1.2% |
| 22 | IDXX IDEXX Laboratories, Inc. | Medical - Diagnostics & Research | $54.3B | 1.5% | 0.4% |
| 23 | A Agilent Technologies, Inc. | Medical - Diagnostics & Research | $48.4B | 8.1% | 3.6% |
| 24 | WAT Waters Corporation | Medical - Diagnostics & Research | $44.1B | 11.5% | 1.3% |
| 25 | NTRA Natera, Inc. | Medical - Diagnostics & Research | $41.5B | 0.2% | 2.7% |
| 26 | GEHC GE HealthCare Technologies Inc. | Medical - Devices | $37.2B | 26.6% | 7.7% |
| 27 | BIIB Biogen Inc. | Drug Manufacturers - General | $36.9B | 20.7% | 3.5% |
| 28 | RVMD Revolution Medicines, Inc. | Biotechnology | $35.1B | 1.4% | 10.5% |
| 29 | MTD Mettler-Toledo International Inc. | Medical - Diagnostics & Research | $33.9B | 5.9% | 0.2% |
| 30 | ZTS Zoetis Inc. | Drug Manufacturers - Specialty & Generic | $33.8B | 26.4% | 4.5% |
| 31 | RMD ResMed Inc. | Medical - Instruments & Supplies | $33.6B | 1.2% | 3.0% |
| 32 | DXCM DexCom, Inc. | Medical - Devices | $30.5B | 4.1% | 5.9% |
| 33 | RPRX Royalty Pharma plc | Medical - Pharmaceuticals | $30.4B | 28.1% | 1.8% |
| 34 | ILMN Illumina, Inc. | Medical - Diagnostics & Research | $30.4B | 6.3% | 4.4% |
| 35 | LH Labcorp Holdings Inc. | Medical - Diagnostics & Research | $29.9B | 19.3% | 0.9% |
| 36 | WST West Pharmaceutical Services, Inc. | Medical - Instruments & Supplies | $28.8B | 0.7% | 1.6% |
| 37 | DGX Quest Diagnostics Incorporated | Medical - Diagnostics & Research | $28.3B | 21.8% | 2.8% |
| 38 | INSM Insmed Incorporated | Biotechnology | $26.5B | 2.6% | 4.3% |
| 39 | STE STERIS plc | Medical - Specialties | $25.0B | 7.4% | 2.1% |
| 40 | UTHR United Therapeutics Corporation | Biotechnology | $24.7B | 0.0% | 8.3% |